Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status

INTRODUCTION: Retrospective studies suggest that p53 alteration is prognostic for recurrence in patients with urothelial bladder cancer and predictive for benefit from combination methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) adjuvant chemotherapy. PATIENTS AND METHODS: Patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Stadler, Walter M., Lerner, Seth P., Groshen, Susan, Stein, John P., Shi, Shan-Rong, Raghavan, Derek, Esrig, David, Steinberg, Gary, Wood, David, Klotz, Laurence, Hall, Craig, Skinner, Donald G., Cote, Richard J.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2011
Subjects:
Original Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3164246/
https://ncbi.nlm.nih.gov/pubmed/21810677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.34.4028
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items